Canbex VSN16R first in man study

• Research type

  Research Study

• Full title

  Phase 1 Exploratory, Double-blind, Randomised, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VSN16R Following Single and Multiple Ascending Doses in Healthy Young Male Subjects

• IRAS ID

  135674

• Contact name

  James Ritter

• Contact email

  james.ritter@quintiles.com

• Sponsor organisation

  Canbex

• Eudract number

  2013-002765-18

• REC name

  HSC REC B

• REC reference

  13/NI/0115

• Date of REC Opinion

  24 Sep 2013

• REC opinion

  Further Information Favourable Opinion